Concept of stress ulcer prophylaxis: Is a change of mind necessary?;Konzept der stressulkusprophylaxe: Ist ein umdenken erforderlich?

Medizinische Klinik

Volumn 93, Issue 8, 1998, Pages 486-491

  Kress, Stephan ^a,b   Schilling, Dieter ^a,b   Riemann, Jürgen Ferdinand ^a,b  

^a Medizinische Klinik C Klinikum   (Germany)

^b Klinikum Ludwigsliafcii Gginbh

Author keywords

Incidence; Indication; Pathogenesis; Prophylaxis; Risk factors; Stress ulcers

Indexed keywords

ANTACID AGENT; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; RANITIDINE; SUCRALFATE;

ARTIFICIAL VENTILATION; BLOOD CLOTTING DISORDER; CLINICAL TRIAL; CRITICAL ILLNESS; DIFFERENTIAL DIAGNOSIS; ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HEAD INJURY; HEALTH CARE COST; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; META ANALYSIS; PRESCRIPTION; REVIEW; RISK FACTOR; STRESS ULCER;

EID: 0032529553     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03042598     Document Type: Review

References (91)

1. Alverdy JC, Aoys E, Moos GS. Total parenteral nutrition promotes tucterûl tramlocation from the gur. Surgery 1988;104:185-90.
2. Rill esteras MA, Hogan DL, Koss MA, IsenbergJI. Uolus or intravenous infusion of ranitidine: Effects on gastric pH and acid secretion. Ann Intern Med 1990;112:334-9.
3. Basso N, Uagarani M, Mjteria A, Fiorani S, LunarJi I', Speranza V. Cinietidine and antacid prophylaxis of acute upper gastrointestinal bleeding in higli risk patients. Ain J Surg 1981;141:339-41.
4. Bauernfeind P, Starlinger M. Role of blood flow in mucosal damage and protection. EurJ Gastroentcrol Hepatol 1990;2:182.
5. Baumann G, Loher U, Felix SD, et al. Deleterious effects of cimetidine in the presence of histamine on coronary circuhtion. Res Exp Med 1982;180:209-13.
6. Beil AR, Mannix H, 13eal JM. Massive upper gastrointestinal hemorrhage after operation. Am J. Surg I964;108:324-32/
7. Dorrero E, Bank S, Margolis I, Schulman N, Chardavoyne R. Comparison of antacid and sucralfate in the prevention of gastrointestinal bleeding in patients who are critically ill. AmJ Med 1985;79:6-74.
8. Castiglione F, Jehle EC, lîlum AL. Kontroversen um die Streßblutungsprophylaxe. Dtsch Mcd Wochenschr 1990;115:1408-10.
9. Cheung LY. Pathophysiology of stress-induced gastric niucos.il erosions: An update. Surg Gastroentcrol 1982;!: 235-12.
10. Cook DJ, Pearl RG, Cook RJ, Guyatt GH. The incidence of clinically important bleeding in ventilated patients. J Intens Care Med 1991 ;6:167-74.
11. Cook DJ, Witt LG, Cook RJ, Guyatt GH. Streß ulcer prophylaxis in the critically ill. A metaanalysis. AmJ Med 1991;91:519-27.
12. Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Medt994;330:377-81.
13. Cook DJ, Reeve BK, Guyatt GH, et al. Stress ulcer prophylasis in critically ill patients. Resolving discordant meta-analyses.JAMA 1996;275:3S-14.
14. Czaja AJ, McAlhanyJC, Pruitt DA. Acute gastroduodenal disease after thermal injury: An endoscopie evaluation ofincidence and natural history. N EnglJ Med 1974;291: 925-9.
15. Daschner F, Reuschenbach K, PflstererJ, et al. Der Einfluß von Streßulkusprophylaxe auf die Häufigkeit einer Beatmungspneumonie. Anaesthesist 1987;36:9-18.
16. Driks MR, Craven DE, Celli BR, et al. Nosocomial pneumonia in incubated patients randomized to sucralfäte versus antacids and/or histamine type 2 blockers. The role gastric colonisation. N EnglJ Med 1987;317:1376-82.
17. Ephgrave KS, Klemian-Wexler RL, Adair CG. Enterai nutrients prevent stress ulcération and increase intragastric volume. Crit Care Med 1990;18:621-4.
18. Fiddian-Green RG, McCough E, Pittenger G, Rothman E. Predictive value of intramural pH and other risk factors for massive bleeding from stress ulcérations. Gastroenterology 1983;85:613-20.
19. Fogelman MJ, GraveyJM. Acute gastroduodenal ulcération incident to surgery and disease: Analysis and review of eighty-eight cases. AmJ Surg 1966;112:651 -6.
20. Fong Y, Marano MA, Barber A, et al. Total parenteral nutrition and bowel rest modify the metabolic response to endotoxin in humans. Ann Surg 1989;2IO:449-56.
21. Friedman Cj, Obhnger MJ, Surati PM, et al. Prophylaxis of upper gastrointestinal hemorrhage in patients requiring mechanical ventilation. Crit Care Med 1982;10:316-9.
22. Gyr K, Meier R. Streßulkuskrankheit und deren Prophylaxe. Aktuelle Analyse. Schweiz Med Wochenschr 19S9;119:423-9.
23. GottliebJE, Menashe PI, Cruz E. Gastrointestinal complications in critically ill patients: the intensivists1 overview. AmJ Gastroenterol 19S6;81:227-38.
24. Hase T, Anderson PR, Mehlmann P. Significance of gastric secretory changes in pathogenesis of stress ulcers. Dig DisScil975;20:443-9.
25. Hastings PR, Skillman JJ, Bushnell LS, Silen W. Antacid titration in the prevention of acute gastrointestinal bleeding. A controlled randomised trial in 100 critically ill patients. N Engl J Med 1978;298:1041-5.
26. Idjadi F, Robbins R, Stahl WM, Essiet G. Prospective study of gastric secretion in stressed patients with intracranial injury. J Trauma 1971;! 1:681-8.
27. I toll M, Guth PH. Role of oxygen derived free radicals in hemorrhagic shock-induced gastric lesions in the rat. Gastroemerology 19S5;88:1162.
28. Jehle EC, Castighone F, lîlum AL. Prophylaxe der Streßulkusblutung: Kosten-Nutzen-Analyse. Z Gastroenterol 1990;28:315-21 .
29. Kamada T, Fusamoto H, Kawano S, et al. Gastrointestinal bleeding following head injury: A clinical study of 433 cases.J Trauma 1977;17:44-7.
30. Khan F, Parekh A, Patel S, Chitkara R, Rehman M, Goyal R. Results of gastric neutralisation with hourly antacids and cimetidine in 320 incubated patients with respiratory failure. Chest 1981;79;409-12.
31. Kirch W, Haiabi A, Linde M. Santas SR, Ohnhaus EE. Negative effects of famotidine on cardiac performance assessed by noninvasive hemodynamic measurements. Gastroenterology 1989,96:1388-92.
32. Kitamura T, Ho K. Acute gastric changes in patients with acute stroke. Part 1: With reference to gastroduodenoscopic findings. Stroke 1976;7:460-3.
33. Kivilaakso E. Prostaglandîn cytoprotection during hemorrhagic shock induced gastric stress lesions. Gastroenterol Clin IîioM985;9:122.
34. Kohler B, Benz C, Maier M. Jakobs R, Riemann JF. Omeprazol versus Ranitidin - Dauerinfusion bei der akuten Ulkusblutung- EfHzienrkomrolle durch intragastrale Langzeit-pH-Metrie. 2 Gastroenterol 1994;32:536.
35. Kussin P, Sacks MS, Chalmers TC. Stress ulcer prophylaxis in the critically ill: Quality assessment and metaanalysis of randomised controlled trials. Gastroenterology 19S5;83:1715.abstract.
36. Lacroix J, Infante-Rîvard C, Gauthier M. Upper-gastrointestinal bleeding (UGIU) prophylaxis: a decision-making analysis and cost/benefit analysis. Clin Invest Med 19S6;9:A22.abstract.
37. LacroixJ, Nadeau D, Laberge S, Gauthïer M, Lapierre G, Farrell CA. Frequency of upper gastrointestinal bleeding in a pédiatrie intensive care unit. Crit Care Med 1992;20: 35-42.
38. Lacy ER. Gastnc epithelial and membrane restitution. EurJ Gastroenterol Hepatol 1990;2:178.
39. Laggner AN, Lenz K, Graninger W, et al. Streßblutungsprophylaxe auf einer internen Intensivstation: Sucraltat vs. Raniridin. Anästhesist 198S;37:704-10.
40. Larson G.M, West G, McGraw P. Intracranial pressure, çascrin, and acid secretion in severe head injury. Surg Forum 19S2;33:175.
41. Larson CM, Koch S, O'Dorisio TM, Osadchey B, McGraw P, Richardson JD. Gastric response to severe head injury. AmJ Surg 19S4;147:97-105.
42. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. NEnglJMedl9SS;318:1728-33.
43. LeGallJR, Mignan FC, Rapin M, et al. Acute gastroduodenal lesions related to severe sepsis. Surg Gynecol Obstet 1976; 142:377-80.
44. Lucas CE, Sugawa C, Riddle J, Rector F, Rosenberg B, Walt AJ. Natural history and surgical dilemma of stress gastric bleeding. Arch Surg 1971;102:266-73.
45. Mahul P, Auboyer C, Josepe R, et al. Prevention of nosocomial pneumonia in intubated patients: respective role of mechanical subglottic secretions drainage and stress ulcer prophylaxis. Intern CareMed 1992;18:20-5.
46. Marrone GC, Sileb W. Pathogenesis, diagnosis and treatment of acute gastric mucosal lesions. Clin Gastroenterol 19S4;13:635-50.
47. Martin LF, Max MH, Polk. HC. Failure ofgastric pH control by antacids or cimetidine in the critically ill. A valid sign of sepsis. Surgery 19SO;88:59-68.
48. Martin LF, McBooth FV, Reines HD, et al. Stress ulcers and organ failure in intubated patients in surgical intensive care units. Ann Surg 1992;215:332-7.
49. Mattews JU, Tortella BJ. Gastroduodenal hemorrhage and perforation in the postoperative period. Surg Gynecol Obstet 19S8;167:3S9-92.
50. McAlhanyJC, Czaya AJ, Pruitt BA. Antacid control of compliance from acute gastroduodenal disease after burns.J Trauma 1976;16:645-9.
51. McClelland RN, Shires GT, Prager M. Gastric secretory and splanchnic blood flow studies in man after severe trauma and hemorrhagic shock. AmJ Surg 1971;12:134-12.
52. McNaughton WK, WallaceJL. A role for dopamine as an endogenous protective factor in rat stomach. Gastroentrologyl9S9;96:972-SO.
53. Menguy R, Desbailets L, Masters YF. Mechanism of stress ulcer Influence of hypovolaemic shock on energy metabolism in the gastric mucosa. Gastroenterology1974;66:46-55.
54. Miller T.A. Mechanisms of stress-related mucosal damage. AmJ Med 1987;83:S-14.
55. Moore FA, Moore TN, Jones TN. McCroskey BL, Pecerson VM. TEN versus TPN folio ing major abdominal trauma. Reduced septic morbidity. J Trauma 19,S9;29: 916-22.
56. Norseworthy TW, Shustack A, RGJohnston, Andersen 13J, Konopad E, Grace M. A randomized clinical trial comparing ranitidine and antacids in critically ill patients. Cric Care Med 1937;15:817-9.
57. Ostro MJ. Rüssel JA, Soldin SJ, Mahon WA.Jeejeebhoy KN. Control of gastric pH with cimetidine: Bolus venus primed infusions. Gastroenterologe 1985;89:532-7.
58. Peura DA, Johnson LF. Cinietidine for prevention and treatment of gastroduodenal inucosal lesions in patients in an intensive care unit. Ann Intern Med 1985;103:173-7.
59. Peura DA. Koretz RL. Prophylactic therapy of stress-related mucosal damage: Why, which, who, and so what? AmJ Gastroenterol 1990;85:935-7.
60. Pingleton SK, Hadzima S. Enterai alimentation and gastrointestinal bleeding in mechanically ventilated patients. Crit Care Med 1983;! 1:13-5.
61. Pingleton SK. Hinthorn DR, Lui C. Enterai nutrition in patients receiving mechanical ventlation. Am J Med 19S6;SO:827-32.
62. Pingelton SR. Gastric bleeding and/or (?) enterai feeding. Chest 19S6;90:2-3.
63. PinillaJC, Oleniuk FH, Reed D, Malik li, Laverty WH. Docs antacid prophylaxis prevent upper gastrointestinal bleeding in critically ill patients? Crit Care Med 1985;13:646-50.
64. Prod'hoin G, Leunenberger P, Koerfer J, et al. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or surcralfate as prophylaxis for stress ulcer. Ann Intern Med 1994; 120:653-62.
65. Poleski MH, Spanier AH. Cinietidine versus antacids in the prevention of stress erosions in critically ill patients. AmJ Gasiroenterol I986;81:107-ll.
66. Rees WDW. Mucus-bicarbonate barrier -shield or sieve. Gut 19S7;28:1553-6.
67. Robert A, KautTman GI. Stress ulcers, erosions, and gastric inucosal injurys. In: Steisinger MH, Fordtran JS, eds. Gastrointestinal disease. Paihophysiology, diagnosis, management, 4th edn. Philadelphia: Saun Jen, 1989:772-92.
68. Sanders SW, 13uchi KN, Moore JG, Bishop A. Pharmacodynamics of intravenous ranitidine after bolus and contineous infusion in patients with healed duodenal ulcers. Chn Pliannacol Ther 1989;46:545-51.
69. Santucci L, Fiarucci S, Pelli A, Calderazzo A, Iaisini E, Calderazzo PI, Morrelli A. Controll ofgastric pH with ranitidine in critically ill patients. Comparison of two intraveneous regimens. Dig Dis Sei 1991 ;36:583-7.
70. Schepp W, Sehusdzïarra V. Classen M. Streßulkusprophylaxe 1995. Abwägen zwischen gastrointestinaler Blutung und nosokomialer Pneumonie. Dtsch Med Wochenschr 1995;120:573-9.
71. Schiessel R, Starlinger M, Wolf A, et al. Failure of cimetîdine to prevent gastroduodenal ulcération and bleeding after renal transplantation. Surgery 1981;90:456-8.
72. Schiessel R. Therapie und Prophylaxe streßinduzierter Lasionen. Z Gastroenterol 19S9;27:19-23.
73. Schindelbeck NE, Lippen M, Heinrich C, Muller-Lissner SA. Intragastric bile acid concentrations in critically ill, artificially ventilated patients. Am J. Gastroenterol 19S9;84:624-8.
74. Schuster DP, Rowley H, Feinstein C, McGue MK, Zuckerman GR. Prospective evaluation of the risk ofupper gastrointestinal bleeding after admission to a medical intensive care unit. AmJ Nled 1984;76:623-30.
75. Seyle H. The general adaptation syndrome and the diseases ofadaptation.J Clin Endocrinol 1946;6:117-230.
76. Seyle H. The alarm reaction and the disease of adaption. Ann Inter Med 1978;29:403.
77. Shoemaker WC, Uland RD, Appel PL. Therapy of critically ill postoperative patients based on the outcome prediction and prospective clinical trials. Surg Clin North Aml9S5;65:8Il.
78. Shuman RB, Schuster DP, Zuckerman DO. Prophylactic therapy for stress ulcer bleeding: A reapraisal. Ann Intern Med 1987;106;562-7.
79. Skillrmn JJ. Bushnell LS, Goldman H, Silen W. Respiratory failure, hypotension, sepsis, and jaundice. A clinical syndrome associated with lethal hemorrhage from acute stress ulcération of the stomach. J Surg 1969;! 17:523-9.
80. Stannard VA, Hutchinson A, Morris DL, liyrne A. Gastric exocrine failure in critically ill patients. Incidence and associated features. BrMedJ 1988;296:155-6.
81. Stothert JC, Simonowitz DA, Dellinger EP, et al. Randomized prospective evaluation ofcimetidine and antacid control of gastric pH in the critically ill. Ann Surg 19SO;192:169-72.
82. Takeuchi K, Nishmaki H, Okabe S. ElTects ofdopamine on gastric mucosal lesions induced by ethanol in rats. Possible involvement of antigastric motor activity mediated with alpha 2-ad 2-adrenorecepton. Dig Dis Sei 1988;33:1561-4.
83. Tryba M, Huchzermeyer H, Török M, Zenz M, l'ahlow J. Single-drug and combined medication with cimetidint?, antacids and pirenzepme in the prophylaxis ofacute upper pstrointesrin.il bleeding. Hepato-Gastroemerology 1983; 30:154-7.
84. Tryba M. Risk, ofacute stress bleeding and nosocomial pneumonia in ventilated intensive care unit patients: sucralfate versus antacids. AmJ Med 1987;83:117-24.
85. Tryba M, Kurz-Müller K, Zschachlitz L, Thole H. Rationelle Streßblutungiprophylaxe. Wirksamkeit, Nebenwirkungen, Kosten. Klin Wochenschr 1991 ;69:196-207.
86. Valentine RJ, Turner WW, lîonnan R, Weigelt JA. Does nasoenteral feeding afTord adequate pastroduodenal stress prophylaxis? Crit Care Med 19S6;14:599-605.
87. Virchow R. l listorisches. Kritisches und Positives zur Lehre der UnteileibafTektionen. Vircho\\ s Arch 1853;5:363.
88. Weigelt JA, Aurbokken CM, Gewerts 13L, Snyder WH. Cinietidine versus antacids in prophylaxis for stress ulcé ration. Arch Surg 1981;116:597-601.
89. U'ilcox CM, SpenneyJG, Stress ulcer prophylaxis in medical patients. Who, what and how much? Am J. Gastroenterol 1988;83:1199-211.
90. Zinner MJ, Zuidema Gl), Smith PL, Mignosa M. The prevention of upper gastrointestinal tract bleeding in an intensive care unit. Surg Gynecol Obstet 1981 ;153:214-20.
91. Zuckemun GR, Shuman R. Therapeutic goals and treatment options for prevention of stress ulcer syndrome. AmJ Med 1987:83:29-35.